WWD : Mulberry Board Joins Challice in Rejecting New Offer from Frasers Group

Mulberry Board Joins Challice in Rejecting New Offer from Frasers Group
Mulberry's board has described Frasers' offer for the brand as "untenable," and agrees with majority owners Challice Ltd. that it should cease its pursuit of the company.

LONDON – Mulberry’s board of directors has joined majority owners Challice Ltd. in rejecting Frasers Group’s beefed-up bid for the company.

On Tuesday, the board said it is “unanimously of the view” that Frasers’ preliminary offer is “untenable,” and that Mulberry should continue to focus its attention on driving the commercial performance of the business.

Earlier this month Challice, which is controlled by Ong Beng Seng and Christina Ong, rejected Frasers’ proposal and asked the group, which is controlled by the retail tycoon Mike Ashley, to walk away.

As reported earlier this month, Frasers’ increased its proposed cash offer to around 111 million pounds from 83 million pounds, equivalent to 1.50 pounds for each Mulberry share.

Challice, which holds a 56.4 percent stake in Mulberry, said it would not sell its shares, and made clear that Frasers’ bid would be unsuccessful. Frasers is Mulberry’s largest minority shareholder, with around 37 percent of shares.

On Tuesday, the Mulberry board reiterated its support for the new chief executive Andrea Baldo and said that a new debt facility and capital raise underwritten by Challice “will put the group on a firm footing to ensure we are well set up for future growth.”

The board also acknowledged Frasers’ support for Mulberry and the recent capital raise, and said it looks forward to further interactions with Frasers in the future.

Per London Stock Exchange rules, Frasers has until Oct. 28 to announce a firm intention to make an offer for Mulberry, or confirm that it does not intend to do so.

Ashley specializes in buying stakes in distressed companies, or in companies such as Mulberry, which sell through his retail chains.

Frasers has described Mulberry’s latest financial results as “catastrophic,” and said it strongly believes it can provide the “appropriate insulation and investment to support a much-loved British brand. As part of the Frasers portfolio, the Mulberry brand would be provided with the platform to ensure its long-term survival and success.”

As reported, Mulberry swung to a pretax loss of 34.1 million pounds amid declining revenue and increased operational costs in the 12 months to March 30. Mulberry is one of many luxury accessories brands to be hit by a slowdown in demand, especially from Chinese consumers.

Last month, as part of a plan to help the business, Challice underwrote a capital raise worth 10 million pounds.

While Frasers may cast itself as Mulberry’s savior, the company hasn’t exactly proven itself as a great caretaker of luxury brands.

Late last year, it purchased Matches at a knockdown price of 52 million pounds, and then placed it into administration shortly afterward. Frasers quickly repurchased the IP, while administrators sold off millions of pounds of fashion stock, leaving many of Matches’ designers and brands trying to recoup their losses.

>>> Freeport-McMoRan beats by $0.01, beats on revs

Freeport-McMoRan beats by $0.01, beats on revs
  • Reports Q3 (Sep) earnings of $0.38 per share, excluding non-recurring items, $0.01 better than the FactSet Consensus of $0.37; revenues rose 16.6% year/year to $6.79 bln vs the $6.45 bln FactSet Consensus.
    • Consolidated production totaled 1.1 bln pounds of copper, 456 thousand ounces of gold and 20 mln pounds of molybdenum in Q3.
    • Consolidated sales totaled 1.0 bln pounds of copper, 558 thousand ounces of gold and 19 mln pounds of molybdenum in Q3.
  • 2024 Outlook: Consolidated sales are expected to approximate 4.1 bln pounds of copper, 1.8 mln ounces of gold and 80 mln pounds of molybdenum for the year 2024, including 980 million pounds of copper, 340 thousand ounces of gold and 20 million pounds of molybdenum in Q4.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • BOOM -17.2% (guidance, strategic review, and chairman shakeup), MEDP -10.9%, GPC -10.2%, SHW -8.3%, LOGI -7.8%, PII -7.7%, SSD -4.3%, GE -4%, KMB -4%, IPG -3.5%, NUE -2.7%, IVZ -2.3%, HXL -2%, HRI -1.6%, VZ -1.5%, CADE -1.4%, SIGI -1.2%, KREF -1.1%, AOS -1%, SCCO -0.8%
Other news:
  • NNE -8.6% (stock offering)
  • IIIN -4.5% (acquires Engineered Wire Products for $70 mln)
  • ASPN -3.9% (prices offering of 4.25 mln shares of common stock at $20.00 per share) SSL -3.7% (Q3 production)
  • MRX -2.2% (stock offering)
  • BOW -1.8% (launches public offering of 4.0 mln shares of its common stock by certain of its stockholders; issues guidance)
Analyst comments:
  • CSIQ -4.7% (downgraded to Sell from Neutral at Citigroup)
  • COHR -2.9% (downgraded to Neutral from Buy at Rosenblatt)
  • TGLS -1.5% (downgraded to Mkt Perform from Strong Buy at Raymond James)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • MLI +9.6%, FLXS +6.2%, MMM +4.9%, SAP +3.5%, RLI +2.8%, ZION +2.8%, DGX +2.1%, RTX +2%, HSTM +1.9%, PM +1.7%, BKU +1.6%, PNR +1.5%, PHM +1.4%, ARE +1.2%, WTFC +1.1%, DHR +1.1%, BOKF +1%, CATY +0.9%, ONB +0.9%, PEBO +0.8%, GM +0.8%, LMT +0.5%
Other news:
  • IRTC +16.5% (FDA grants clearance for 510(k) submission related to design changes made to the Zio AT device)
  • IMUX +11.9% (announces a positive outcome of the non-binding, interim futility analysis of its phase 3 ENSURE program, investigating lead asset, nuclear receptor related 1 activator, vidofludimus calcium, for the treatment of relapsing multiple sclerosis)
  • MOLN +5.2% (Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics)
  • CAKE +3.7% (activist urging to consider breakup, according to WSJ)
  • WT +3.7% (WTAM agreed to resolve the matter by consenting to the entry of an Order by the SEC)
  • RDHL +3.1% (collaboration with a leading U.S. academic medical center to develop Opaganib as a countermeasure against phosgene inhalation injury)
  • MGNX +2.6% (MacroGenics and TerSera Therapeutics LLC have entered into an agreement in which TerSera will acquire global rights to MARGENZA)
  • CLLS +2.5% (to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress)
  • ANNX +2.5% (Presents Phase 2 Vision Preservation Data with ANX007)
  • FUFU +2.5% (has entered into a definitive agreement to acquire a majority stake in an 80-megawatt Bitcoin mining facility in Ethiopia)
  • NRIX +2% (presentations announced to summarize new data)
  • OMC +1.8% (files mixed shelf)
  • DAR +1.6% (publishes collagen peptides study)
  • CRC +1.5% (Kern County approves of conditional use permit for CTV I carbon capture)
  • ESEA +1.1% (new 3-year time charter contracts)
  • CRDL +1% (plans to expand the MAVERIC clinical development program and advance CardiolRx into a late-stage clinical trial to evaluate the impact of CardiolRx)
Analyst comments:
  • FSLR +1.9% (upgraded to Buy from Neutral at Citigroup)
  • FLR +1.5% (upgraded to Buy from Neutral at Citigroup)
  • AEG +0.9% (upgraded to Buy from Neutral at UBS)
  • PCTY +0.9% (upgraded to Buy from Hold at Jefferies)

>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Aegon N.V. (AEG) upgraded to Buy from Neutral at UBS
    • First Solar (FSLR) upgraded to Buy from Neutral at Citigroup; tgt raised to $254
    • Fluor (FLR) upgraded to Buy from Neutral at Citigroup; tgt raised to $65
    • Paylocity (PCTY) upgraded to Buy from Hold at Jefferies; tgt raised to $200
  • Downgrades:
    • Canadian Solar (CSIQ) downgraded to Sell from Neutral at Citigroup; tgt lowered to $11
    • Coherent (COHR) downgraded to Neutral from Buy at Rosenblatt; tgt $105
    • Duke Energy (DUK) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • Gatos Silver (GATO) downgraded to Hold from Buy at Canaccord Genuity
    • Global Payments (GPN) downgraded to Mkt Perform from Outperform at Bernstein; tgt lowered to $112
    • Tecnoglass (TGLS) downgraded to Mkt Perform from Strong Buy at Raymond James
  • Others:
    • Applied Industrial (AIT) initiated with an Outperform at Mizuho; tgt $285
    • AppLovin (APP) initiated with a Buy at Loop Capital; tgt $181
    • Braze (BRZE) initiated with a Buy at Stifel; tgt $37
    • Cadence Design (CDNS) initiated with an Outperform at Mizuho; tgt $325
    • California Resources Corp (CRC) initiated with an Overweight at Stephens; tgt $73
    • Contineum Therapeutics (CTNM) initiated with an Outperform at Robert W. Baird; tgt $32
    • Costco (COST) initiated with an Outperform at Bernstein; tgt $1016
    • Dollar General (DG) initiated with an Outperform at Bernstein; tgt $98
    • Dollar Tree (DLTR) initiated with a Mkt Perform at Bernstein; tgt $76
    • Flex (FLEX) initiated with an Overweight at KeyBanc Capital Markets; tgt $41
    • Hershey Foods (HSY) initiated with a Sell at Redburn Atlantic; tgt $165
    • Home Depot (HD) initiated with a Mkt Perform at Bernstein; tgt $451
    • Insperity (NSP) initiated with an Underweight at JP Morgan; tgt $90
    • Klaviyo (KVYO) initiated with a Buy at Stifel; tgt $45
    • Lowe's (LOW) initiated with an Outperform at Bernstein; tgt $323
    • Mondelez Int'l (MDLZ) initiated with a Buy at Redburn Atlantic; tgt $82
    • Plexus (PLXS) initiated with a Sector Weight at KeyBanc Capital Markets
    • Synopsys (SNPS) initiated with an Outperform at Mizuho; tgt $650
    • Target (TGT) initiated with a Mkt Perform at Bernstein; tgt $168
    • Walmart (WMT) initiated with an Outperform at Bernstein; tgt $95
    • Zeta Global (ZETA) initiated with an Overweight at KeyBanc Capital Markets; tgt $40

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • IRTC +18.6%, FLXS +9.2%, MOLN +8.1%, RYAM +5.7%, FUFU +5.4%, CAKE +4.8%, SAP +3%, DHR +2.9%, RLI +2.8%, ANNX +2.5%, NRIX +2%, HSTM +1.9%, OMC +1.8%, IPAR +1.8%, ZION +1.8%, CADE +1.7%, EDIT +1.6%, DAR +1.6%, CRC +1.5%, CLLS +1.4%, ESEA +1.1%, WTFC +1.1%, BOKF +1%, IHG +1%, BLND +0.9%, CATY +0.9%, ARE +0.8%, PEBO +0.8%
  • Gapping down:
    • BOOM -17.4%, MEDP -11.4%, LOGI -8.2%, PII -7.2%, NNE -6.5%, BOW -4.8%, SSL -4.8%, MRX -4.6%, IIIN -4.5%, SSD -4.5%, ASPN -3.4%, NUE -3.3%, HXL -2%, COHR -1.9%, SIGI -1.2%, KREF -1.1%

FT : Walmart and Amazon take on US pharmacies in prescription delivery

Walmart and Amazon take on US pharmacies in prescription delivery
Launch of same-day services puts new pressure on struggling drugstore chains such as CVS and Walgreens

Walmart and Amazon are promising same-day deliveries in the $600bn US prescription medicines market, putting new pressure on drugstores and supermarkets that compete against the nation’s two largest retailers.

Retail giant Walmart on Tuesday said it would launch same-day delivery nationwide by the end of January, sending out prescription drugs from its almost 4,600 outlets containing pharmacies. The company says 90 per cent of the US population lives within 10 miles of its stores. 

The move follows almost two weeks after Amazon announced it would expand same-day medications delivery to 45 per cent of US customers by the end of 2025 as it adds pharmacy service sites in 20 more cities in the US, including Philadelphia, Dallas and San Diego. 

Their initiatives come amid upheaval in the US pharmacy industry, where revenues from dispensing prescriptions totalled $621bn in 2023, excluding Covid-19 vaccines, according to the Drug Channels Institute. 

CVS, the owner of the largest US drugstore chain, replaced chief executive Karen Lynch with David Joyner last week as it struggles with challenges, including retail competition. Its shares have fallen 28 per cent this year.

Walgreens Boots Alliance, the second-largest pharmacy operator, plans to close 1,200 stores over the next few years as it battles ballooning losses and a 60 per cent fall in its stock this year. The Rite Aid chain went through bankruptcy reorganisation last year. 

Meanwhile, the Federal Trade Commission has sued to block what would be the nation’s largest supermarket merger, Kroger’s $24.6bn takeover of Albertsons, arguing in part that it would diminish customer service at their in-house pharmacies. 

There is also mounting concern about “pharmacy deserts”, or areas without a conveniently located drugstore. Even as it competes with brick-and-mortar pharmacies, Amazon has said its “digital-first” pharmacies would help fill such gaps. 

Many independent pharmacies have long delivered medicines, sending drivers out to local customers, and both CVS and Walgreens offer same-day delivery with certain restrictions. Mail-order pharmacy is a growing industry, but deliveries take days and are typically reserved for recurring prescriptions. 

Amazon opened its online pharmacy service in 2020. The ecommerce company began offering same-day delivery last year in several US cities, including its home base of Seattle, and moved into New York and Los Angeles earlier this year. 

Hannah McClellan, vice-president of operations, product and technology at Amazon Pharmacy, told a press event earlier this month that the company’s pharmacies would be integrated into the same-day delivery network used for other Amazon products. 

“Amazon Pharmacy is not a faster mail-order pharmacy that you have today. It’s not the online version of your neighbourhood drugstore,” she said. 

Amazon says most of its pharmacy customers currently receive their medications in two days or less. Same-day deliveries in most cases would mean an order received by 4pm would arrive by 10pm. 

Walmart said its same-day prescription drugs delivery will begin in six states immediately and reach 49 by the end of January, with delivery times as short as half an hour.

>>> Makor Oscar Gruss & ACG Analytics: U.S. Elections Update with PDF

Good Morning,

We are hosting a US election call with ACG analytics (they will be live from the IMF conference in Washington)

Thursday 24th of October at 5pm London time / 12pm NY

(See attached)

Laurent Chekroun​​​​
Equity Sales
Makor Securities London Ltd. | Makor Group
E: LCHEKROUN@makor-cm.com
M: +41 79 350 71 09
O: +33 1 42 33 02 05
W: www.makor-group.com
6th Floor, 30 Panton Street, London, SW1Y 4AJ
This message has been sent by Makor Securities, London, part of Makor Group, which is authorised and regulated by the FCA (625054). This message is for professional clients and eligible counterparties only, not intended for "retail clients".  The information contained in this message is confidential and is for the exclusive use of the intended recipient. If you receive this message in error please inform us and delete all copies of it. The information is not intended as an offer or solicitation to buy or sell any financial instrument. All comments and statements are to be considered the opinions of the author not the Company and are not intended to be relied upon. We cannot guarantee that this message or any attachments are virus free and accept no liability for any viruses or the consequences thereof. v20230124

The Information : How Stripe’s $1.1 Billion Crypto Bet Could Pay Off

How Stripe’s $1.1 Billion Crypto Bet Could Pay Off

The Takeaway
• Bridge customers include Scale AI processor Airtm
• Payments giants are embracing stablecoins for moving money globally
• Bridge was valued at $100 million in a late 2023 funding round

Crypto fans have argued for years that blockchain technology could speed up global payments and make them cheaper. Now payments giant Stripe is making a more than $1 billion bet on that finally becoming a reality—and the crypto industry is rejoicing.

Stripe announced on Monday that it had agreed to acquire Bridge, a two-and-a-half-year-old San Francisco–based startup focused on payments using stablecoins, a type of crypto pegged to a traditional currency. With estimated annual revenue of around $12 million, based on its transaction volume and people with knowledge of its fee structure, Bridge is fetching an eye-popping multiple of around 90 times revenue.

Bridge helps companies convert dollars or euros into blockchain-based stablecoins and use those stablecoins to pay their workers or suppliers overseas. It pitches its services as an improvement for companies over traditional forms of international payments, which involve sending money through correspondent banks that communicate via the Swift network.

Its customers include Airtm, a payment processor that works with fast-growing data-labeling startup Scale AI, underlying how some businesses are starting to embrace crypto.

The deal values Bridge at $1.1 billion and if completed would be the largest-ever crypto acquisition. Bridge, which makes money by charging fees based on transaction volumes, said in August its annualized payments volume had reached $5 billion. It charges 0.1% to 0.25%, according to people at firms that have been quoted on prices, which means its revenue at the high end would be about $12.5 million.

The sale is a remarkable outcome for Bridge, which was valued at about $100 million in a late 2023 Series A, according to people familiar with the figure. Bridge has raised a total of around $58 million from investors including Ribbit Capital, Index Ventures and Sequoia Capital, also a major Stripe investor.

The hefty price tag could be worth it for Stripe, which was recently valued at $70 billion in an employee tender. The company has been trying to find more ways to expand its payments business by using crypto to add speedy payments and quickly sign up customers around the globe.

Stablecoins have been a hot area of focus for crypto companies as well as traditional payment firms over the past year. Compared to using bitcoin, which is notoriously volatile in value, stablecoins have a set value, making them easier to use for payments purposes. And business customers may be easier to pitch than consumers—merchants might save money by accepting payments in crypto rather than credit cards, for example.

More acquisitions in the stablecoin sector could be coming. Bhanu Kohli, CEO and co-founder of Layer2 Financial, recently renamed Rail, which provides services similar to Bridge’s, said his firm has received acquisition interests from payment companies and crypto firms, though he has no plan to sell.

Bridge’s roughly 45-person team, including co-founders Zach Abrams and Sean Yu, is expected to join Stripe once the deal is completed, people familiar with the deal said. Abrams was previously chief product officer at small business banking startup Brex and head of consumer product at crypto exchange Coinbase. He and Yu, a former engineer at Coinbase and Airbnb, previously co-founded Evenly, a Venmo competitor, and sold it to Square in 2013.

“This is definitely a premium company in terms of the talent and the growth they are experiencing,” said Haun Ventures partner Chris Ahn.

Still, Bridge relies heavily on the traditional financial system to operate. Bridge receives dollars from the companies it works with via its U.S. bank account, and uses those funds to buy stablecoins from Circle and Tether. Those companies issue the stablecoins and manage the cash and other reserves that back them up.

Bridge then sends the stablecoins to contractors and suppliers on behalf of the companies it works with. But those recipients still need to cash out stablecoins into local currencies, so Bridge partners with a network of local crypto services such as Bitso in Mexico and Yellow Card in Africa.

For example, Scale AI gives overseas contractors workers the option to get paid in stablecoins. Scale AI’s payment processor, Airtm, in turn uses Bridge behind the scenes to enable stablecoin payments. Scale first funds its account with Airtm by wiring U.S. dollars to Bridge’s bank account. From there, Bridge uses the funds to buy stablecoins, and then sends them to contractors’ crypto wallets via Airtm.

While that process might sound convoluted, stablecoin proponents say it is still a cheaper and faster way than traditional payment methods for companies to make cross-border payments. It also allows companies to quickly send payments to users that don’t have their own bank accounts, as well as people in countries such as Pakistan where big payment companies like PayPay don’t operate.

Rubén Galindo Steckel, founder and CEO of Airtm, said AI contractors are the service’s fastest-growing segment. “Airtm can allow someone who works for Scale AI to cash out their money into their local currency in six minutes,” with the recipient paying fees of about 2.5%, he said.

Creators and streamers on social sites who are based overseas and don’t have bank accounts can also use stablecoins to receive payouts, Steckel said.

Crypto U-Turn

The deal to acquire Bridge comes after Stripe made an about-face on using crypto for payments in recent months. Stripe had stopped supporting bitcoin payments in 2018, blaming high costs, slow transaction times and the difficulty of using volatile bitcoin as a payment method.

In April, Stripe’s co-founder and president, John Collison, unveiled a feature that allows merchants using Stripe-powered checkouts to accept stablecoins. At the time, Stripe had already been working with Paxos, a rival stablecoin startup, to provide stablecoin services, according to a person familiar with the relationship.

Bridge had also been pursuing Stripe as a potential customer in recent months, and those conversations evolved into deal talks, according to one person familiar with the conversation. Bridge provides the same functionality as Paxos. It’s unclear whether Stripe’s work with Paxos, which was valued at $2.4 billion in 2021, will continue once the Bridge deal closes.

Stripe and Paxos declined to comment.

Embracing stablecoins for payments comes with some risks for Stripe. Stablecoins are not yet a legal form of money in the U.S., meaning they are subject to limited federal oversight and consumer protections. And U.S. lawmakers have struggled to make progress on legislation to provide a regulatory framework for stablecoins, creating uncertainty that could give some companies pause about adoption.

Stripe’s crypto initiatives have also made at least one of its major banking partners uneasy in the past. Wells Fargo, which formerly powered Stripe’s credit card payments, raised concerns about Stripe’s efforts to expand crypto payments. Wells Fargo wound up cutting ties with Stripe and other payment firms entirely. It was part of a broader retrenchment of banks from working with payments companies and other fintechs amid mounting regulatory scrutiny.